Literature DB >> 26652007

Functional characterization of CYP2D6 novel allelic variants identified in the Chinese Han population.

Qingqing Xu1, Zhenqiang Wu1, Lun Yang1, Xiaoqing Zhang2, Zhongtao Gai3, Lili Chen1, Lin He1,4, Shengying Qin1,4.   

Abstract

AIM: This study was aimed to functionally characterize four novel CYP2D6 alleles identified in Chinese Han population. MATERIALS &
METHODS: CYP2D6 proteins of wild-type and the four novel variants along with CYP2D6.2 and CYP2D6.10 were heterologously expressed in yeast cells and the kinetic parameters were determined.
RESULTS: Compared with CYP2D6.1 (frequency in Chinese 24.65%), CYP2D6.X (1.63%), CYP2D6.Y (1.50%), CYP2D6.Z (0.81%), CYP2D6.10 (52.53%) and CYP2D6.75 (0.13%) exhibited low activity at different degrees, whereas the kinetic parameters of CYP2D6.2 (11.06%) were much the same with CYP2D6.1. The novel allele CYP2D6.75 showed decreased enzyme activity.
CONCLUSION: This is the first study to conduct functional analysis of CYP2D6 four novel alleles in Chinese Han population, which might be helpful for optimizing pharmacotherapy and the design of personalized medicine.

Entities:  

Keywords:  CYP2D6; Han Chinese; allele; functional characterization; pharmacogenomics

Mesh:

Substances:

Year:  2015        PMID: 26652007     DOI: 10.2217/pgs.15.148

Source DB:  PubMed          Journal:  Pharmacogenomics        ISSN: 1462-2416            Impact factor:   2.533


  2 in total

1.  Association of CYP2D6*10 (c.100C>T) polymorphisms with clinical outcome of breast cancer after tamoxifen adjuvant endocrine therapy in Chinese population.

Authors:  Lei Lei; Xian Wang; Xiao-Dan Wu; Zeng Wang; Zhan-Hong Chen; Ya-Bin Zheng; Xiao-Jia Wang
Journal:  Am J Transl Res       Date:  2016-08-15       Impact factor: 4.060

2.  Functional characterization of the chlorzoxazone 6-hydroxylation activity of human cytochrome P450 2E1 allelic variants in Han Chinese.

Authors:  Ting Wang; Huihui Du; Jingsong Ma; Lu Shen; Muyun Wei; Xianglong Zhao; Luan Chen; Mo Li; Guorong Li; Qinghe Xing; Lin He; Shengying Qin
Journal:  PeerJ       Date:  2020-07-31       Impact factor: 2.984

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.